|
OxytrolDrug - Oxytrol The trade name of the product as shown on the labeling.
Dosage -
FILM, EXTENDED RELEASE; TRANSDERMAL
Active Ingredient(s) -
Oxybutynin
Strength -
3.9MG/24HR
Applicant -
WATSON LABS (UTAH)
New Drug Application (NDA) Number -
021351
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Feb 26, 2003
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Watson Laboratories Inc
Oxytrol
Oxtriphylline 200mg Tablet, Delayed Release; Oral
Choledyl Sa 400mg Tablet, Extended Release; Oral Choledyl Sa 600mg Tablet, Extended Release; Oral Oxytrol 3.9mg/24hr Film, Extended Release; Transdermal Oxtriphylline 100mg/5ml Solution; Oral Choledyl 50mg/5ml Syrup; Oral Oxtriphylline Pediatric 50mg/5ml Syrup; Oral Choledyl 100mg Tablet, Delayed Release; Oral Choledyl 200mg Tablet, Delayed Release; Oral Oxtriphylline 100mg Tablet, Delayed Release; Oral NewDrugInformation |